← Leaderboards
Inmaculada Hernandez
University Of Pittsburgh At Pittsburgh
$2,420,658
Attributed
$2,420,658
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $768.6K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,420,658 · 2
By mechanism
R01$1,622,924 · 1
K01$797,734 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Manisha Jhamb$6,862,629
- Hilary A. Tindle$15,133,646
- Adeel A Butt$975,610
- Khaled A Abdel-Kader$2,565,864
- Julie Marie Donohue$17,269,798
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectWarfarinOralStrokeStroke RiskAreaFee-For-Service PlansMedicarePublic Health RelevancePreventStroke IncidenceStroke PreventionCardiovascular DiseasesCardiovascular SystemAnticoagulantsAdherenceAtrial FibrillationIncidenceAnticoagulationPatient-Focused OutcomesBeneficiaryDiagnosisBaseApplications Grants
Grant awards (8)
Pandemic Disruptions of Atrial Fibrillation Care$505,596
R01 · FY2023 · HL · contact PI
Pandemic Disruptions of Atrial Fibrillation Care$508,338
R01 · FY2022 · HL · contact PI
Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation$159,703
K01 · FY2022 · HL · contact PI
Pandemic Disruptions of Atrial Fibrillation Care$608,990
R01 · FY2021 · HL · contact PI
Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation$159,586
K01 · FY2021 · HL · contact PI
Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation$159,637
K01 · FY2020 · HL · contact PI
Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation$159,504
K01 · FY2019 · HL · contact PI
Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation$159,304
K01 · FY2018 · HL · contact PI